FR2622456B1 - RECOMBINANT FOWLPOX VIRUSES, HETEROLOGOUS PROTEIN EXPRESSION VECTORS AND POULTRY VACCINES DERIVED FROM THIS VIRUS - Google Patents

RECOMBINANT FOWLPOX VIRUSES, HETEROLOGOUS PROTEIN EXPRESSION VECTORS AND POULTRY VACCINES DERIVED FROM THIS VIRUS

Info

Publication number
FR2622456B1
FR2622456B1 FR8715001A FR8715001A FR2622456B1 FR 2622456 B1 FR2622456 B1 FR 2622456B1 FR 8715001 A FR8715001 A FR 8715001A FR 8715001 A FR8715001 A FR 8715001A FR 2622456 B1 FR2622456 B1 FR 2622456B1
Authority
FR
France
Prior art keywords
virus
expression vectors
protein expression
heterologous protein
recombinant fowlpox
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8715001A
Other languages
French (fr)
Other versions
FR2622456A1 (en
Inventor
Robert Drillien
Daniele Spehner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR8715001A priority Critical patent/FR2622456B1/en
Priority to FR888808226A priority patent/FR2632863B2/en
Priority to DE3888086T priority patent/DE3888086T2/en
Priority to EP88402695A priority patent/EP0314569B1/en
Priority to AT88402695T priority patent/ATE102252T1/en
Priority to ES88402695T priority patent/ES2061708T3/en
Priority to JP63272864A priority patent/JP2766984B2/en
Priority to US07/264,493 priority patent/US5180675A/en
Priority to DK198806038A priority patent/DK175291B1/en
Priority to AU24458/88A priority patent/AU633472B2/en
Priority to CA000581654A priority patent/CA1341263C/en
Publication of FR2622456A1 publication Critical patent/FR2622456A1/en
Application granted granted Critical
Publication of FR2622456B1 publication Critical patent/FR2622456B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8715001A 1987-10-29 1987-10-29 RECOMBINANT FOWLPOX VIRUSES, HETEROLOGOUS PROTEIN EXPRESSION VECTORS AND POULTRY VACCINES DERIVED FROM THIS VIRUS Expired - Fee Related FR2622456B1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR8715001A FR2622456B1 (en) 1987-10-29 1987-10-29 RECOMBINANT FOWLPOX VIRUSES, HETEROLOGOUS PROTEIN EXPRESSION VECTORS AND POULTRY VACCINES DERIVED FROM THIS VIRUS
FR888808226A FR2632863B2 (en) 1987-10-29 1988-06-20 RECOMBINANT FOWLPOX VIRUS AND VACCINES DERIVED FROM SUCH VIRUSES
EP88402695A EP0314569B1 (en) 1987-10-29 1988-10-26 Recombinant fowlpox virus, expression vectors for heterologous proteins, and vaccines for fowl derived from this virus
AT88402695T ATE102252T1 (en) 1987-10-29 1988-10-26 RECOMBINANT POULTRY POX VIRUS, EXPRESSION VECTORS FOR HETEROLOGICAL PROTEINS AND POULTRY VACCINE DERIVATIVES.
ES88402695T ES2061708T3 (en) 1987-10-29 1988-10-26 RECOMBINANT VIRUSES OF THE GALLINA SMALLPOX, VECTORS OF EXPRESSION OF HETEROLOGICAL PROTEINS AND VACCINES FOR POULTRY DERIVED FROM THIS VIRUS.
DE3888086T DE3888086T2 (en) 1987-10-29 1988-10-26 Recombinant fowlpox virus, expression vectors for heterological proteins and fowl vaccine derived therefrom.
JP63272864A JP2766984B2 (en) 1987-10-29 1988-10-27 Recombinant poultry pox virus
US07/264,493 US5180675A (en) 1987-10-29 1988-10-28 Recombinant fowlpox virus
DK198806038A DK175291B1 (en) 1987-10-29 1988-10-28 Recombinant virus
AU24458/88A AU633472B2 (en) 1987-10-29 1988-10-28 Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
CA000581654A CA1341263C (en) 1987-10-29 1988-10-28 Recombinant fowlpox virus, heterologous protein expression vectors, and fowl vaccines derived from this virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8715001A FR2622456B1 (en) 1987-10-29 1987-10-29 RECOMBINANT FOWLPOX VIRUSES, HETEROLOGOUS PROTEIN EXPRESSION VECTORS AND POULTRY VACCINES DERIVED FROM THIS VIRUS

Publications (2)

Publication Number Publication Date
FR2622456A1 FR2622456A1 (en) 1989-05-05
FR2622456B1 true FR2622456B1 (en) 1990-02-02

Family

ID=9356295

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8715001A Expired - Fee Related FR2622456B1 (en) 1987-10-29 1987-10-29 RECOMBINANT FOWLPOX VIRUSES, HETEROLOGOUS PROTEIN EXPRESSION VECTORS AND POULTRY VACCINES DERIVED FROM THIS VIRUS

Country Status (1)

Country Link
FR (1) FR2622456B1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429965A (en) * 1966-08-01 1969-02-25 Sterling Drug Inc Avian pox virus vaccine and process of preparing same
WO1986000528A1 (en) * 1984-07-05 1986-01-30 Genex Corporation Cloned gene and method for making and using the same
EP0218625B1 (en) * 1985-03-29 1995-04-05 Btg International Limited Infectious bronchitis virus spike protein
FR2583429B1 (en) * 1985-06-18 1989-11-03 Transgene Sa INTERFERON U EXPRESSION VECTOR IN MAMMALIAN CELLS, PROCESS FOR IMPLEMENTING SAME AND PRODUCT OBTAINED, AND PHARMACEUTICAL COMPOSITION CONTAINING INTERFERON U
AU602875B2 (en) * 1985-12-18 1990-11-01 British Technology Group Limited Newcastle disease virus gene clones

Also Published As

Publication number Publication date
FR2622456A1 (en) 1989-05-05

Similar Documents

Publication Publication Date Title
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
ATE144552T1 (en) RECOMBINANT FOWLPOX VIRUS
DE69016956D1 (en) Recombinant turkey herpes virus and derived live vaccine vector.
DE3583293D1 (en) LYMPHADENOPATHY-ASSOCIATED SHELL ANTIGENS AND THEIR USE.
ATA257190A (en) VIRAL POLYPEPTIDE
DK672788D0 (en) RECOMBINANT DNA VECTORS FOR DIRECT EXPRESSION OF ACTIVATED HUMANT PROTEIN C
DE68919846D1 (en) POXVIRUS VECTORS.
FR2620459B1 (en) RECOMBINANT VACCINE VIRUS
DE3853088D1 (en) Recombinant avipox virus.
ATE206434T1 (en) SEROREACTIVE AREAS ON THE HPV 16 PROTEINS E1 AND E2
ID24174A (en) VECTOR OF PORCINE ADENOVIRUS
ZA923321B (en) Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus
DE3850019T2 (en) Recombinant avipox virus.
HU9300187D0 (en) Applications of recombinant dna of synoythioma virus proteines, vaccines, antibodies and transformed cells of cattle's breathing organs
ITMI913092A1 (en) RECOMBINANT POXVIRUS VACCINE OF THE MORBILLO VIRUS
NO922421D0 (en) COLLAGEN-BINDING PROTEIN, AND PREPARATION OF THEREOF
FR2622456B1 (en) RECOMBINANT FOWLPOX VIRUSES, HETEROLOGOUS PROTEIN EXPRESSION VECTORS AND POULTRY VACCINES DERIVED FROM THIS VIRUS
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
NO892269L (en) NON-HYPERGYLYCOSYLED HEPATITY B VIRUS PROTEINS AND EXPRESSION "CASSETTE" AND PROCEDURE FOR THE PREPARATION OF THE PROTEINS.
ES2061850T3 (en) RECOMBINANT VIRUSES OF MAREK'S DISEASE, ITS PREPARATION PROCEDURE AND VACCINE.
DE3855076T2 (en) Bovine plague virus vaccine using recombinant vaccinia virus
FR2481316B1 (en) RECOMBINANT DNA TECHNIQUE FOR THE PREPARATION OF A HUMAN INTERFERON-LIKE PROTEIN
DE69130675T2 (en) CLONING AND EXPRESSION OF A RHOPTRY-ASSOCIATED PROTEIN FROM P. FALCIPARUM
ATE102252T1 (en) RECOMBINANT POULTRY POX VIRUS, EXPRESSION VECTORS FOR HETEROLOGICAL PROTEINS AND POULTRY VACCINE DERIVATIVES.
FR2655855B1 (en) GENETIC PROTECTION OF ANIMALS AGAINST INFECTION WITH THE BOVINE LEUCEMOGEN VIRUS, AND PROVIRUS AND RECOMBINANT VIRUS DERIVED FROM THIS VIRUS.

Legal Events

Date Code Title Description
ST Notification of lapse